Feature
The health and social care sector shows signs of recovery, but health and social care experts are unsure how this will play out in the M&A market.
M&A
Feature
Feature
Social care experts widely see the Casey Review’s 2028 release date as a delay tactic and wonder if some businesses will even survive to see its conclusion.
Politics & policy
Feature
The Government has announced its plans to tackle the elective care backlog and to strengthen the partnership between the public and private sectors. Some observers have déjà vu.
Politics & policy
Feature
The largely untapped UK consumer healthcare market is ripe for opportunity, according to SunWave CEO Tom Zivanovic. HealthInvestor finds out more.
Interview
Feature
Neil Eastwood is looking to tackle the care sector’s workforce crisis. Not only does his app offer a novel solution, but his experience as a former carer and care group director gives him a fascinating perspective on where employers are going wrong.
Interview
Feature
Hours-long ambulance waits have prolonged patient suffering, but what if calling an ambulance was as simple as ordering an Uber? HealthInvestor interviews Max Korotich, co-founder of ambulance app FlashAid.
Interview
Feature
Oakland Care’s purchase of a 70-bed care home development site last month highlights key trends in the elderly care market.
Market analysis
Feature
Nearly two-thirds of care and support providers will make redundancies following the the NI and national living wage hikes. HealthInvestor speaks to a workforce expert.
Feature
Aziz Ul-Haq discusses how LDC is supporting its healthcare portfolio companies to achieve their growth strategies in a fast-moving market.
Sponsored Content
Feature
Forbes Stuart, partner at Ignite Growth, which acquired supported living business Acorns Healthcare, talks bout Ignite’s regional growth strategy, his thoughts on UK political risk and more.
Interview
Feature
Younes Fegheh-Hassanpour, R&D tax manager at financial advisor RCK Partners explains how the UK can spark global competitiveness in the life sciences industry
Pharma
Feature
Jay Shah ponders whether CDMO deals will revive next year to define pharma M&A.
Pharma
Feature
Marion Jeng, associate at investment bank DAI Magister, identifies the femtech sectors healthcare investors should prioritise.
Feature
PR firm The PHA Group's Rob Scott-Collins describes how businesses can thrive in a prevention first world
Politics & policy
Feature
Vicky Bullen, global chief executive of design agency Coley Porter Bell says the healthcare system needs a cure for brand homogeneity.
Feature
The DC Advisory global healthcare team takes a detailed look into the healthcare M&A landscape
M&A
Feature
Kevin Keck, a partner at Phoenix Equity Partners explains how the UK’s private and public healthcare systems can co-exist successfully for better patient outcomes
Politics & policy
Feature
Dealmakers say there are indications of a growing increase in M&A in the healthcare sector this year, as Murat Basboga reports.
Market analysisMost read
Feature
Social care experts widely see the Casey Review’s 2028 release date as a delay tactic and wonder if some businesses will even survive to see its conclusion.
Politics & policy
Feature
The Government has announced its plans to tackle the elective care backlog and to strengthen the partnership between the public and private sectors. Some observers have déjà vu.
Politics & policy
Feature
The largely untapped UK consumer healthcare market is ripe for opportunity, according to SunWave CEO Tom Zivanovic. HealthInvestor finds out more.
Interview
Feature
Neil Eastwood is looking to tackle the care sector’s workforce crisis. Not only does his app offer a novel solution, but his experience as a former carer and care group director gives him a fascinating perspective on where employers are going wrong.
Interview
